434 related articles for article (PubMed ID: 30355560)
1. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
[TBL] [Abstract][Full Text] [Related]
3. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
Lester EG; Gates MV; Vranceanu AM
Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
[TBL] [Abstract][Full Text] [Related]
4. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
[TBL] [Abstract][Full Text] [Related]
5. Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
Lester E; DiStefano S; Mace R; Macklin E; Plotkin S; Vranceanu AM
Gen Hosp Psychiatry; 2020; 62():72-78. PubMed ID: 31841875
[TBL] [Abstract][Full Text] [Related]
6. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract][Full Text] [Related]
7. Live Video Adaptations to a Mind-Body Activity Program for Chronic Pain and Cognitive Decline: Protocol for the Virtual Active Brains Study.
Mace RA; Doorley JD; Popok PJ; Vranceanu AM
JMIR Res Protoc; 2021 Jan; 10(1):e25351. PubMed ID: 33208301
[TBL] [Abstract][Full Text] [Related]
8. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
Reichman M; Riklin E; Macklin E; Vranceanu AM
Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
[TBL] [Abstract][Full Text] [Related]
9. A Live Video Program to Prevent Chronic Pain and Disability in At-Risk Adults With Acute Orthopedic Injuries (Toolkit for Optimal Recovery): Protocol for a Multisite Feasibility Study.
Vranceanu AM; Bakhshaie J; Reichman M; Doorley J; Elwy AR; Jacobs C; Chen N; Esposito J; Laverty D; Matuszewski PE; Fatehi A; Bowers LC; Harris M; Ring D
JMIR Res Protoc; 2021 Apr; 10(4):e28155. PubMed ID: 33908886
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
Fishbein NS; Vranceanu AM; Mace RA
J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
[TBL] [Abstract][Full Text] [Related]
11. Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study.
Mizrach H; Goshe B; Park ER; Recklitis C; Greer JA; Chang Y; Frederick N; Abrams A; Tower MD; Walsh EA; Huang M; Kenney L; Homans A; Miller K; Denninger J; Usmani GN; Peppercorn J; Perez GK
JMIR Res Protoc; 2022 Jan; 11(1):e34033. PubMed ID: 35080500
[TBL] [Abstract][Full Text] [Related]
12. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract][Full Text] [Related]
13. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
[TBL] [Abstract][Full Text] [Related]
14. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
[TBL] [Abstract][Full Text] [Related]
15. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.
Greenberg J; Carter S; Lester E; Funes CJ; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2019 Dec; 145(3):561-569. PubMed ID: 31677033
[TBL] [Abstract][Full Text] [Related]
16. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation.
Bannon SM; Hopkins SW; Grunberg VA; Vranceanu AM
J Neurooncol; 2022 Feb; 156(3):519-527. PubMed ID: 35064449
[TBL] [Abstract][Full Text] [Related]
18. Mobile Phone Support for Diabetes Self-Care Among Diverse Adults: Protocol for a Three-Arm Randomized Controlled Trial.
Nelson LA; Wallston KA; Kripalani S; Greevy RA; Elasy TA; Bergner EM; Gentry CK; Mayberry LS
JMIR Res Protoc; 2018 Apr; 7(4):e92. PubMed ID: 29636319
[TBL] [Abstract][Full Text] [Related]
19. Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention.
Funes CJ; Zale EL; Luberto CM; Vranceanu AM
Complement Ther Med; 2019 Feb; 42():114-118. PubMed ID: 30670227
[TBL] [Abstract][Full Text] [Related]
20. A Virtual Resiliency Intervention Promoting Resiliency for Parents of Children with Learning and Attentional Disabilities: A Randomized Pilot Trial.
Park ER; Perez GK; Millstein RA; Luberto CM; Traeger L; Proszynski J; Chad-Friedman E; Kuhlthau KA
Matern Child Health J; 2020 Jan; 24(1):39-53. PubMed ID: 31650412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
